CIRCADIAN TECHNOLOGIES LIMITED

Type: Company

Name: CIRCADIAN TECHNOLOGIES LIMITED

First Reported Mar 14 2010 - Updated Mar 15 2010 - 3 Documents

Minerals Corporation shares rise on low carbon cement production plans in China

Minerals Corporation (ASX: MSC) has announced the commencement of regular production of its low carbon cement products in April 2010. This production will be at its joint venture plant in Shanghai.The company says this is a low cost location and is also ... [Published Mar 15 2010 by Proactive Investors.co.uk]

Entities: MINERALS CORPORATION LIMITED, Shanghai, Carbon

First Reported Mar 12 2010 - Updated Mar 12 2010 - 1 Documents

Australian Securities Exchange

Circadian Technologies to present at Ultimate Healthcare & Biotechnology Event, March 24

The directors of Bionomics Ltd , Pulse Health Ltd , Circadian Technologies Ltd , Medical Australia Ltd , Stirling Products Ltd , CogState Ltd and Phylogica Ltd invite you to attend at Proactive Investors' "The Ultimate Healthcare & Biotechnology Event ... [Published Mar 12 2010 by Proactive Investors.co.uk]

Entities: Australian Securities Exchange, CIRCADIAN TECHNOLOGIES LIMITED, Biotechnology

First Reported Mar 10 2010 - Updated Mar 11 2010 - 3 Documents

US investment bank issues bullish note on Circadian Technologies

US-based investment bank Merriman Curhan Ford has issued a research report on local biotechnology company Circadian Technologies (ASX: CIR) with a BUY rating and a A$2.20-2.88 price per share target range. The Circadian share price currently sits at ... [Published Mar 11 2010 by Proactive Investors.co.uk]

Entities: CIRCADIAN TECHNOLOGIES LIMITED, Antibody, Ligand, Biotechnology, Receptor

First Reported Dec 07 2009 - Updated Dec 08 2009 - 1 Documents

Commonwealth Scientific and Industrial Research Organisation (CSIRO)

Circadian Technologies & CSIRO forge landmark alliance to develop cancer treatments

Melbourne-based biologics drug developer Circadian Technologies (ASX: CIR) and the CSIRO have announced a collaboration to advance the development of cancer treatments. Robert Klupacs managing director of Circadian said, "we are extremely excited ... [Published Dec 07 2009 by Proactiveinvestors United Kingdom RSS feed]

Entities: Commonwealth Scientific and Industrial Research..., CIRCADIAN TECHNOLOGIES LIMITED, Cancer, Molecule, Protein

First Reported Nov 19 2009 - Updated Nov 19 2009 - 1 Documents

Circadian Technologies CEO Robert Klupacs tells AGM: "significant upside"

<p>Robert Klupacs, CEO of Circadian Technologies (ASX: CIR) told the Annual General Meeting that a transformation had been made by Circadian from a “biotechnology investor and incubator of early stage technologies” - to focused developer of biological ... [Published Nov 19 2009 by Proactiveinvestors United Kingdom RSS feed]

Entities: CIRCADIAN TECHNOLOGIES LIMITED, Antibody, Tumor, ImClone Systems Incorporated, Diagnostic

First Reported Nov 17 2009 - Updated Nov 17 2009 - 1 Documents

ImClone Systems Incorporated

Circadian Technologies CEO Robert Klupacs to present at Merriam Curhan Ford Investor Summit in NYC

<p>Victorian-based Circadian Technologies (ASX: CIR) a developer of novel, biological-based treatments for cancer has advised that Robert Klupacs, CEO and Managing Director will be presenting at Merriman Curhan Ford’s 6th annual Investor Summit in New ... [Published Nov 17 2009 by Proactiveinvestors United Kingdom RSS feed]

Entities: CIRCADIAN TECHNOLOGIES LIMITED, Merriam (United States), Australian Securities Exchange, ImClone Systems Incorporated

First Reported Oct 29 2009 - Updated Oct 29 2009 - 1 Documents

Circadian Technologies subsidiary terminates licence to Ark Therapeutics

Circadian Technologies Limited (ASX:CIR), a developer of novel, biologics-based treatments for cancer, announced today that its subsidiary Vegenics Limited has terminated the licence previously granted to Ark Therapeutics Limited, under its VEGF-D gene ... [Published Oct 29 2009 by Proactiveinvestors United Kingdom RSS feed]

Entities: CIRCADIAN TECHNOLOGIES LIMITED, Ark Therapeutics plc, Arbitration, Gene Therapy

First Reported Oct 13 2009 - Updated Oct 13 2009 - 1 Documents

Circadian Technologies produces VGX-300 protein in sufficient quantity and yield for first time

Drug developer for Circadian Technologies (ASX: CIR) has ticked a key box in its VGX-300 cancer therapeutics program to assist cancer patients. By achieving the production of the VGX-300 protein in cell culture in sufficient quantity and yield for ... [Published Oct 13 2009 by Proactiveinvestors United Kingdom RSS feed]

Entities: CIRCADIAN TECHNOLOGIES LIMITED, Protein, Tumor

Quotes

18/03/10 Healthcare & Biotech companies to present at "Ultimate Healthcare & Biotechnology Event 2010”"

Dragon Mountain Gold encouraged by initial drilling at Wa Wu Gou prospect in China [Proactive Investors.co.uk - 5 hours ago]

"The fact that the rally was small and short-lived indicates to us that the shorter-term players are not really positioned as short at the moment" Gero said

Gold futures down to $1,102/oz, silver down to $17.04/oz [Proactive Investors.co.uk - Mar 14 2010]

More Content

sort by: Date \| Relevance
Dragon Mountain Gold encouraged by initial dril... [Proactive Investors.co.uk - 5 hours ago]
Manganese ore output in China fell by 34% in 2009 [Proactive Investors.co.uk - 10 hours ago]
Minerals Corporation shares rise on low carbon ... [Proactive Investors.co.uk - Mar 15 2010]
Falcon Minerals completes capital raising for N... [Proactive Investors.co.uk - Mar 15 2010]
Rubianna Resources expects drilling to commence... [Proactive Investors.co.uk - Mar 15 2010]
Gold futures down to $1,102/oz, silver down to ... [Proactive Investors.co.uk - Mar 14 2010]
China's growth boosting commodity prices [Proactive Investors.co.uk - Mar 14 2010]
Circadian Technologies to present at Ultimate H... [Proactive Investors.co.uk - Mar 12 2010]
US investment bank issues bullish note on Circa... [Proactive Investors.co.uk - Mar 11 2010]
US Broker: "Circadian Technologies The Che... [Proactiveinvestors United Kingdom RSS feed - Mar 10 2010]
US Broker: "Circadian Technologies The Che... [Proactive Investors.co.uk - Mar 10 2010]
Leading ASX Healthcare companies to present at ... [Proactive Investors.co.uk - Feb 24 2010]
Circadian Technologies & CSIRO forge landma... [Proactiveinvestors United Kingdom RSS feed - Dec 07 2009]
Circadian Technologies CEO Robert Klupacs tells... [Proactiveinvestors United Kingdom RSS feed - Nov 19 2009]
Circadian Technologies CEO Robert Klupacs to pr... [Proactiveinvestors United Kingdom RSS feed - Nov 17 2009]
Circadian Technologies subsidiary terminates li... [Proactiveinvestors United Kingdom RSS feed - Oct 29 2009]
Circadian Technologies produces VGX-300 protein... [Proactiveinvestors United Kingdom RSS feed - Oct 13 2009]
Vegenics' VEGF-D receives European patent for a... [PharmaBiz - Jun 22 2009]

Advanced Search Options

CIRCADIAN TECHNOLOGIES LIMITED